DexCom Inc (DXCM NASDAQ) stock market data APIs
$91.3213
-1.46(-1.6%)
as of August 28, 2026
Try our APIs with
free plan!
DexCom Inc Financial Data Overview
Price chart is built with
Anychart
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Prev. Close
91.3213
Open
89.8646
High
91.654
Low
88.7176
52 wk Range
54.11-92.59
Market Cap
34 272 M
P/E Ratio
35.3385
Shares Outstanding
377 M
Revenue
4 969 M
EPS
0.7
Beta
1.41
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with DexCom Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DexCom Inc data using free add-ons & libraries
Get DexCom Inc Fundamental Data
DexCom Inc Fundamental data includes:
- Net Revenue: 4 969 M
- EBITDA: 1 403 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-07-30
- EPS/Forecast: 0.61
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DexCom Inc News
New
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories' Libre Duo 10 ...
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories' (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and old...
Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now?
Abbott Laboratories ABT and DexCom DXCM are two of the most prominent players in the continuous glucose monitoring (CGM) space. Abbott has continued to enhance its continuous monitoring portfolio thro...
Stick with value stocks until everyone starts talking about them — they’re still under the radar, this Wall Street firm says
Estée Lauder earns a rank among high-growth stocks beyond AI. - Ian Langsdon/Agence France-Presse/Getty Images In 2021 strategists at Bank of America's BofA Securities advised clients to "stick with...
Get DexCom Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
